17 Jul 2013 07:00
PuriCore plc
("PuriCore" or the "Company")
17 July 2013
Notice of Results
PuriCore (LSE: PURI), a global company focused on safely and effectively protecting people from the spread of infectious pathogens, will announce its interim results for the six months ended 30 June 2013, on Thursday 8 August 2013. PuriCore will also host a conference call and webcast for analysts and investors at 9:30am BST. To participate, please access the webcast through investor.puricore.com and use the conference call details below:
Conference Call Details
From the UK: +44 20 3139 4830
From the US: +1 718 873 9077
Pin code: 14528742#
A recording of the presentation will be archived on the Company's website at investor.puricore.com/events.
Enquiries
UK | US |
FTI Consulting | Sage Strategic Marketing |
Susan Stuart/Simon Conway | Jennifer Guinan |
Victoria Foster Mitchell | +1 610 410 8111 |
+44 (0) 20 7831 3113 | Jennifer@sagestrat.com |
About PuriCore
PuriCore plc (LSE: PURI) is a global company focused on developing and commercialising proprietary solutions that protect people from the spread of infectious pathogens without causing harm to human health or the environment. PuriCore's antimicrobial technology and complementary products are used principally in well-established core businesses and emerging sectors of two broad markets: Health Sciences and Food & Agriculture. In the Health Sciences market, PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. PuriCore's breakthrough wound therapy solution is used to treat chronic and acute wounds including diabetic ulcers and burns as well as atopic dermatitis as dermatologic treatment products. In the Food & Agriculture market, PuriCore's product portfolio provides savings to supermarket retailers in labour costs and improvements in inventory loss of fresh produce and floral products and addresses cross-contamination. In addition, the Company is progressing in its research and development programmes at Oxford University on the use of its technology as an agricultural fungicide. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com.